Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global atherectomy devices market size was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 8.3% during the forecast period. The U.S. market accounted for approximately 40% of global revenue in 2024, while China is emerging as the fastest-growing regional market with a projected CAGR of 9.8%.
Atherectomy devices are minimally invasive surgical tools used to remove atherosclerotic plaque from blood vessels. These catheter-based systems utilize various mechanisms including directional cutting, rotational burring, orbital sanding, or laser ablation to restore blood flow in coronary and peripheral arteries. Major product segments include directional atherectomy (projected to reach USD 850 million by 2031), rotational atherectomy, orbital atherectomy, and laser atherectomy systems.
Market growth is being driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and technological advancements in plaque removal systems. Recent developments include Boston Scientific's 2023 FDA clearance for its next-generation Rotational Atherectomy System and Medtronic's acquisition of Intersect ENT to strengthen its vascular portfolio. The competitive landscape features key players such as Cardiovascular Systems, Spectranetics, and Abbott, who collectively hold over 65% of the market share through their innovative product pipelines.
Rising Prevalence of Cardiovascular Diseases
The global atherectomy devices market is primarily driven by the increasing incidence of cardiovascular diseases, particularly atherosclerosis. Over 17 million deaths annually are attributed to cardiovascular conditions, creating significant demand for minimally invasive treatment options like atherectomy procedures.
Technological Advancements in Device Design
Recent innovations in atherectomy devices, including laser-based systems and improved rotational mechanisms, have enhanced procedural efficacy. The development of fiber-optic guided systems and directional atherectomy catheters has significantly improved clinical outcomes.
The global atherectomy devices market is projected to grow at a CAGR of 6.2% from 2023 to 2028, driven by increasing adoption in peripheral artery disease treatments.
Aging populations in developed regions and improving healthcare infrastructure in emerging economies are further accelerating market growth, with North America currently holding over 45% of the global market share.
MARKET CHALLENGES
High Procedure Costs and Reimbursement Issues
Atherectomy procedures remain significantly more expensive than alternative treatments, with device costs often exceeding $5,000 per unit. Many healthcare systems struggle with reimbursement policies that don't fully cover these advanced interventions.
Other Challenges
Limited Awareness in Developing Regions
Despite growing prevalence, awareness about atherectomy options remains limited in emerging markets, where traditional revascularization methods still dominate treatment protocols.
Risk of Complications and Device Failures
Potential complications such as distal embolization, vessel perforation, and device malfunctions continue to restrain market growth. Recent FDA recalls involving certain rotational atherectomy systems have heightened regulatory scrutiny across the sector.
Emerging Markets and Outpatient Adoption
The shift toward outpatient atherectomy procedures and increasing adoption in Asia-Pacific markets presents significant growth opportunities. Countries like India and China are witnessing double-digit growth rates in adoption of advanced vascular intervention technologies.
Development of combination devices integrating atherectomy with drug-eluting technologies is creating new revenue streams, with several products currently in clinical trials showing promising results.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Directional Atherectomy dominates the device category due to its precision in plaque removal and widespread clinical adoption. Rotational Atherectomy shows significant promise in calcified lesions treatment, while Orbital Atherectomy gains traction for its safety profile. Laser Atherectomy maintains niche usage for complex vascular cases. |
| By Application |
|
Peripheral vascular applications represent the primary growth area as aging populations experience increasing peripheral artery disease. Cardiovascular applications remain critical for coronary interventions, while neurovascular usage shows specialized potential for intracranial atherosclerosis treatment with advanced device miniaturization. |
| By End User |
|
Hospitals remain the dominant end user due to complex procedure requirements and immediate access to multidisciplinary teams. Specialized cardiac centers demonstrate higher adoption rates for innovative atherectomy technologies, while ambulatory surgery centers increasingly incorporate peripheral vascular procedures with optimized reimbursement models. |
| By Technology |
|
Mechanical systems continue to lead in terms of procedural volume and physician familiarity. Laser-based technologies show promise for specific lesion types despite higher costs, while emerging hybrid systems combine the advantages of multiple modalities for superior clinical outcomes in complex cases. |
| By Disease Complexity |
|
Complex calcification cases are driving advanced atherectomy device development as traditional angioplasty proves inadequate. Simple lesions maintain steady procedural volumes, while moderate calcification represents the largest patient cohort where atherectomy demonstrates clear advantages over standard interventions in terms of vessel preparation. |
Athectomy Devices Market Dominated by MedTech Giants with Emerging Niche Players
Boston Scientific and Medtronic lead the global athectomy devices market with significant revenue shares, leveraging their comprehensive portfolios across directional, rotational, and orbital athectomy technologies. The top five players collectively command approximately X% market share, with Cardiovascular Systems and Abbott strengthening their positions through continuous product innovation in peripheral arterial disease treatments.
Specialized players like Avinger and Straub Medical are gaining traction with novel technologies such as image-guided atherectomy systems and thrombectomy solutions. Meanwhile, Terumo and Cardinal Health (Cordis) are expanding their vascular intervention offerings through strategic acquisitions in the athectomy space.
List of Key Athectomy Devices Companies ProfiledBoston Scientific Corporation
Cardiovascular Systems, Inc. (CSI)
Abbott Laboratories
Bayer AG
Straub Medical AG
Cardinal Health (Cordis)
Terumo Corporation
Cook Medical
Biotronik SE & Co. KG
OrbusNeich Medical Group
The global atherectomy devices market is experiencing robust growth, projected to rise from $X million in 2024 to $XX million by 2031 with a CAGR of X%. This expansion is primarily driven by increasing prevalence of peripheral artery disease and coronary artery disease worldwide, coupled with rising demand for minimally invasive surgical procedures.
Other TrendsDirectional Atherectomy Leads Segment Growth
Directional atherectomy devices are expected to reach $XX million by 2031, growing at a X% CAGR. This segment dominates the market due to its clinical effectiveness in removing plaque while minimizing vessel trauma. Technological advancements in catheter-based systems and guidewires are further propelling adoption rates.
Regional Market Dynamics Show North American DominanceThe U.S. accounts for approximately XX% of the global market share in 2024, valued at $X million, while China's market is projected to grow rapidly to $X million by 2031. Europe maintains steady growth due to established healthcare infrastructure and high procedure volumes for peripheral vascular interventions.
Competitive Landscape Consolidation
Key players including Boston Scientific, Medtronic, and Abbott control approximately XX% of the global market revenue. Recent strategic moves include product innovation in orbital atherectomy systems and increased M&A activity to expand geographic presence and product portfolios.
Technology Advancements Fuel Market ExpansionThe market is witnessing accelerated adoption of laser atherectomy systems, particularly for calcified lesions, with projected growth of X% CAGR through 2031. Improvements in device precision, reduced procedure times, and enhanced safety profiles are driving physician preference for advanced atherectomy solutions.
Regional Analysis: Atherectomy Devices MarketEurope
Europe represents the second-largest market for atherectomy devices, with growth concentrated in Germany, France, and the UK. The region shows slower adoption rates due to stringent CE mark requirements and cost-containment measures in national healthcare systems. However, increasing prevalence of calcified lesions in diabetic patients creates demand for advanced atherectomy solutions. Northern European countries lead in adoption of laser atherectomy, while Southern Europe shows preference for rotational devices. Cross-border training programs help standardize techniques, though reimbursement disparities between countries create uneven market growth.
Asia-Pacific
The Asia-Pacific region demonstrates the fastest growth rate for atherectomy devices, driven by improving healthcare access in China and India. Japan leads in technology adoption with its aging population and advanced interventional cardiology programs. Emerging economies face adoption barriers due to high device costs, though local manufacturers are developing more affordable alternatives. Medical tourism for complex vascular interventions boosts exposure to atherectomy technologies in Thailand and Singapore. Regional differences in disease patterns influence device preference, with higher demand for below-the-knee atherectomy systems in South Asia.
Latin America
Latin America shows modest but steady growth in atherectomy device adoption, concentrated in private healthcare sectors of Brazil and Mexico. Economic volatility affects capital equipment purchases, though increasing diabetes prevalence creates clinical need. Local training initiatives by multinational companies help build procedural expertise. Regulatory harmonization efforts across the region aim to accelerate device approvals. The market remains price-sensitive, with hospitals favoring multi-use devices over disposable systems where possible.
Middle East & Africa
The MEA region presents niche opportunities focused on premium healthcare centers in GCC countries. South Africa serves as the main adoption hub in Sub-Saharan Africa, though market penetration remains low. Religious pilgrimages with associated vascular complications drive some demand in Saudi Arabia. Local manufacturing is virtually nonexistent, creating complete import dependence. Market growth correlates with healthcare infrastructure development, with battery-powered atherectomy devices seeing preference in areas with unreliable electricity supply.
This market research report provides a comprehensive analysis of global and regional markets for the forecast period 20252032. It delivers precise and strategic insights derived from a combination of primary and secondary research methodologies.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Biotech and pharmaceutical companies
Investors, consultants, and policy makers
-> Global atherectomy devices market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031.
-> Key players include Boston Scientific, Cardiovascular Systems, Medtronic, Spectranetics, and Abbott, among others.
-> Key growth drivers include rising cardiovascular diseases, increasing minimally invasive procedures, and technological advancements.
-> U.S. accounted for 40% of global revenue in 2024, while China is the fastest-growing market.
-> Emerging trends include next-generation rotational atherectomy systems and strategic acquisitions to strengthen vascular portfolios.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates